13-oxyingenol dodecanoate derivatives induce mitophagy and ferroptosis through targeting TMBIM6 as potential anti-NSCLC agents.

MLA

Wang, Yaxu, et al. “13-Oxyingenol Dodecanoate Derivatives Induce Mitophagy and Ferroptosis through Targeting TMBIM6 as Potential Anti-NSCLC Agents.” European Journal of Medicinal Chemistry, vol. 270, Apr. 2024, p. 116312. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.116312.

APA

Wang, Y., Gu, L., Li, J., Wang, R., Zhuang, Y., Li, X., Wang, X., Zhang, J., Liu, Q., Wang, J., & Song, S.-J. (2024). 13-oxyingenol dodecanoate derivatives induce mitophagy and ferroptosis through targeting TMBIM6 as potential anti-NSCLC agents. European Journal of Medicinal Chemistry, 270, 116312. https://doi.org/10.1016/j.ejmech.2024.116312

Chicago

Wang, Yaxu, Liwei Gu, Jichong Li, Ruqi Wang, Yuan Zhuang, Xiangyun Li, Xinye Wang, et al. 2024. “13-Oxyingenol Dodecanoate Derivatives Induce Mitophagy and Ferroptosis through Targeting TMBIM6 as Potential Anti-NSCLC Agents.” European Journal of Medicinal Chemistry 270 (April): 116312. doi:10.1016/j.ejmech.2024.116312.